ArticleRevista espanola de salud publica2025
[Cost and percentage of health expenditure for the care of patients with Human Immunodeficiency Virus in treatment with antiretrovirals].
Article in Revista espanola de salud publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe disease generates cost in care and the cost of comprehensive care for the Human Immunodeficiency Virus (HIV) has an impact on the health budget. The objective of this paper was to determine the cost and percentage of health expenditure including medicines in the care of patients with HIV on antiretroviral treatment.
methodsA cost study in patients diagnosed with HIV using information from the first and second level of care electronic clinical records was carried out. We worked with 246 patients that made up the total number of those existing at the time of the study. The profile of use of health services, fixed unit cost, variable unit cost, average unit cost, average annual cost per patient, annual cost for a population, and budget exercised by level of care were identified by level of care. The percentage of health spending was estimated based on spending on HIV and the budget spent at each level of care. Statistical analysis included averages percentages and projections.
resultsThe average annual cost at the first level of care was €55.86, at the second level of care €628.30. The average annual cost per patient was €684.16 and the percentage of HIV health spending was 1.41%.
conclusionsThe cost of care for patients with human immunodeficiency virus is high and varies depending on the services used; in the same way the percentage of health expenditure shows the same trend if the percentage of the affected population is considered.
Indexed as
Identifiers
40525416PMC12120348What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.